Function of Myc for Generation of Induced Pluripotent Stem Cells

Chapter
Part of the Stem Cells and Cancer Stem Cells book series (STEM, volume 6)

Abstract

Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells by the transduction of defined factors. c-Myc is one of the original reprogramming factors, and it increases the number of iPS cells generated in both mouse and human systems when it is added to another three factors (Sox2, Oct3/4, and Klf4). However, exogenously expressed c-Myc, especially by retroviruses, causes tumorigenicity in iPSC-derived chimeric mice during long-term observation. Although iPS cells can be generated in the absence of c-Myc, the quality of iPS cells seems to be low. L-Myc, one of the Myc family genes, can efficiently generate both mouse and human iPS cells. Importantly, tumorigenicity is hardly observed in chimeric mice produced with L-Myc iPS cells. The iPS cells generated with L-Myc are safer, of high quality, and therefore are considered to be useful for future clinical applications.

References

  1. Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV (1992) Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol Cell Biol 12(7):3130–3137PubMedGoogle Scholar
  2. Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA, Minna JD (1988) L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol 8(6):2668–2673PubMedGoogle Scholar
  3. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H (1993) Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 13(9):5216–5224PubMedGoogle Scholar
  4. Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251(4998):1211–1217PubMedCrossRefGoogle Scholar
  5. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947–956PubMedCrossRefGoogle Scholar
  6. Brough DE, Hofmann TJ, Ellwood KB, Townley RA, Cole MD (1995) An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol Cell Biol 15(3):1536–1544PubMedGoogle Scholar
  7. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L, Smith A (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450(7173):1230–1234PubMedCrossRefGoogle Scholar
  8. Cole MD (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20:361–384PubMedCrossRefGoogle Scholar
  9. Cole MD, Cowling VH (2008) Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol 9(10):810–815PubMedCrossRefGoogle Scholar
  10. Gurdon JB, Uehlinger V (1966) “Fertile” intestine nuclei. Nature 210(5042):1240–1241PubMedCrossRefGoogle Scholar
  11. Hatton KS, Mahon K, Chin L, Chiu FC, Lee HW, Peng D, Morgenbesser SD, Horner J, DePinho RA (1996) Expression and activity of L-Myc in normal mouse development. Mol Cell Biol 16(4):1794–1804PubMedGoogle Scholar
  12. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz HP, Haenel F, Eilers M (2002) Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10(3):509–521PubMedCrossRefGoogle Scholar
  13. Malynn BA, de Alboran IM, O’Hagan RC, Bronson R, Davidson L, DePinho RA, Alt FW (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14(11):1390–1399PubMedGoogle Scholar
  14. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5):631–642PubMedCrossRefGoogle Scholar
  15. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26(1):101–106PubMedCrossRefGoogle Scholar
  16. Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S (2010) Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci USA 107(32):14152–14157PubMedCrossRefGoogle Scholar
  17. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germ-line competent induced pluripotent stem cells. Nature 448:313–317PubMedCrossRefGoogle Scholar
  18. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409–412PubMedCrossRefGoogle Scholar
  19. Oster SK, Mao DY, Kennedy J, Penn LZ (2003) Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22(13):1998–2010PubMedCrossRefGoogle Scholar
  20. Schwab M, Varmus HE, Bishop JM (1985) Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316(6024):160–162PubMedCrossRefGoogle Scholar
  21. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, Zhou Q, Plath K (2009) Role of the murine reprogramming factors in the induction of pluripotency. Cell 136(2):364–377PubMedCrossRefGoogle Scholar
  22. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T (2001) Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11(19):1553–1558PubMedCrossRefGoogle Scholar
  23. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676PubMedCrossRefGoogle Scholar
  24. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872PubMedCrossRefGoogle Scholar
  25. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW et al (2006) A protein interaction network for pluripotency of embryonic stem cells. Nature 444(7117):364–368PubMedCrossRefGoogle Scholar
  26. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385(6619):810–813PubMedCrossRefGoogle Scholar
  27. Yancopoulos GD, Nisen PD, Tesfaye A, Kohl NE, Goldfarb MP, Alt FW (1985) N-myc can cooperate with ras to transform normal cells in culture. Proc Natl Acad Sci USA 82(16):5455–5459PubMedCrossRefGoogle Scholar
  28. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Center for iPS Cell Research and Application (CiRA)Kyoto UniversityKyotoJapan

Personalised recommendations